Ram Kumar Nema
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ram Kumar Nema has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Ashutosh Kumar Singh
School of Biosciences, Engineering and Technology, VIT Bhopal University, Sehore 466114, India
7 shared publications Bhavna Prajapati
Division of Environmental Biotechnology, Genetics and Molecular Biology, ICMR - National Institute for Research in Environmental Health, Bhopal, 462 030, India
3 shared publicationsMegha Katare Pandey
Department of Translational Medicine, All India Institute of Medical Sciences, Bhopal, 462 020, India
3 shared publications- Mudra Sikenis
Department of Life Science, Sharda School of Bio-Science & Technology, Sharda University, Greater Noida, India
3 shared publications - Pradyumna Kumar Mishra
ICMR-National Institute for Research in Environmental Health
3 shared publications Rajnarayan R. Tiwari
Faculty of Medical Research, Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201 002, India
3 shared publications
Latest Publications
- 10 April 2026
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (6) , 1053-1067
Prevalence of astrovirus-associated gastroenteritis among hospitalized pediatric patients in Asia: A systematic review and meta-analysis
Viral gastroenteritis is a significant public health concern in developing countries, primarily affecting children under five years. Human astrovirus (HAstV) is one of the key viral agents causing gastroenteritis. Despite the global recognition of HAstV as a causative agent of acute gastroenteritis, its impact on Asian populations, particularly among hospitalized children, is lacking. This systematic review and meta-analysis aimed at determining the prevalence of HAstV-associated acute gastroenteritis among hospitalized pediatric patients in Asia. This systematic review and meta-analysis was conducted following PRISMA Guidelines and registered with PROSPERO (ID CRD42024519527). A comprehensive literature search was performed on PubMed, Web of Science and Scopus databases for studies published between January 2000 and December 2023. Keywords related to astrovirus, prevalence, pediatric populations and hospitalization in Asia were used. A pre-designed Excel sheet was used for data extraction and the Joanna Briggs Institute critical appraisal tool was used for quality assessment. Generalized Linear Mixed Models with logit transformation were used to calculate the effect sizes. The analysis included 49 studies, encompassing data from various Asian countries. The pooled prevalence of HAstV in hospitalized pediatric patients due to acute gastroenteritis was 2.39%, highlighting the significant burden in Asia. Sub-group analysis revealed considerable difference in HAstV prevalence among Asian countries. This systematic review and meta-analysis summarizes the prevalence of HAstV among hospitalized pediatric patients in Asia, highlighting the need for country-specific strategies to improve surveillance and diagnostics.
- 10 April 2026
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 45 (6) , 1053-1067
Prevalence of astrovirus-associated gastroenteritis among hospitalized pediatric patients in Asia: A systematic review and meta-analysis
Viral gastroenteritis is a significant public health concern in developing countries, primarily affecting children under five years. Human astrovirus (HAstV) is one of the key viral agents causing gastroenteritis. Despite the global recognition of HAstV as a causative agent of acute gastroenteritis, its impact on Asian populations, particularly among hospitalized children, is lacking. This systematic review and meta-analysis aimed at determining the prevalence of HAstV-associated acute gastroenteritis among hospitalized pediatric patients in Asia. This systematic review and meta-analysis was conducted following PRISMA Guidelines and registered with PROSPERO (ID CRD42024519527). A comprehensive literature search was performed on PubMed, Web of Science and Scopus databases for studies published between January 2000 and December 2023. Keywords related to astrovirus, prevalence, pediatric populations and hospitalization in Asia were used. A pre-designed Excel sheet was used for data extraction and the Joanna Briggs Institute critical appraisal tool was used for quality assessment. Generalized Linear Mixed Models with logit transformation were used to calculate the effect sizes. The analysis included 49 studies, encompassing data from various Asian countries. The pooled prevalence of HAstV in hospitalized pediatric patients due to acute gastroenteritis was 2.39%, highlighting the significant burden in Asia. Sub-group analysis revealed considerable difference in HAstV prevalence among Asian countries. This systematic review and meta-analysis summarizes the prevalence of HAstV among hospitalized pediatric patients in Asia, highlighting the need for country-specific strategies to improve surveillance and diagnostics.
- 12 March 2026
- Published by Elsevier in Next Research
- Vol. 8
An epidemiological review of the one health approach in emerging zoonotic diseases
- 12 March 2026
- Published by Elsevier in Next Research
- Vol. 8
An epidemiological review of the one health approach in emerging zoonotic diseases
- Open Access
- 30 December 2025
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 14 (12) , 4940-4947
The impact of variations in the chikungunya genome on the clinical manifestations and transmission of the disease
A BSTRACT: The Chikungunya virus (CHIKV) has emerged as a public health concern around the world as they have large epidemics. These epidemics are associated not just with mild but also with severe clinical manifestations. CHIKV was first discovered in Tanzania in 1952. Because of climate change, urbanization, and international travel, it has expanded. The rising incidence of diseases primarily transmitted by Aedes aegypti and Aedes albopictus mosquitoes highlights the urgent need for better surveillance, vector control, and therapeutics. CHIKV is an RNA virus that mutates frequently leading to genetic diversity and complicating disease management. In this review, we present how genomic variations of CHIKV can affect clinical presentation and transmission dynamics. We discuss the mutations in CHIKV that were analyzed in various outbreaks. We examine the structural and lifecycle characteristics of CHIKV, followed by a detailed exploration of important genomic modifications in structural (E1, E2) and nonstructural (nsP3) proteins, and their consequences for viral propagation, immune evasion, and pathogenicity. Mutations in the E1 protein, for instance, enhance entry into host cells, while mutations in the E2 protein reduce antibody neutralization. Changes in nsP3 are connected to more replication and disease problems. It is difficult to diagnose, treat, and make vaccines for them. The continuous genetic monitoring of viruses is important to check the new variants that are emerging. A comprehensive approach including better diagnostics, selective vector control, vaccine development, and community-based management would help mitigate CHIKV impact. Through illuminating the link between viral evolution and clinical outcomes, the current review aims to stimulate future research and reinforce preparedness against this ever-evolving virus.
- 30 December 2025
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 14 (12) , 4940-4947
Open AccessThe impact of variations in the chikungunya genome on the clinical manifestations and transmission of the disease
A BSTRACT: The Chikungunya virus (CHIKV) has emerged as a public health concern around the world as they have large epidemics. These epidemics are associated not just with mild but also with severe clinical manifestations. CHIKV was first discovered in Tanzania in 1952. Because of climate change, urbanization, and international travel, it has expanded. The rising incidence of diseases primarily transmitted by Aedes aegypti and Aedes albopictus mosquitoes highlights the urgent need for better surveillance, vector control, and therapeutics. CHIKV is an RNA virus that mutates frequently leading to genetic diversity and complicating disease management. In this review, we present how genomic variations of CHIKV can affect clinical presentation and transmission dynamics. We discuss the mutations in CHIKV that were analyzed in various outbreaks. We examine the structural and lifecycle characteristics of CHIKV, followed by a detailed exploration of important genomic modifications in structural (E1, E2) and nonstructural (nsP3) proteins, and their consequences for viral propagation, immune evasion, and pathogenicity. Mutations in the E1 protein, for instance, enhance entry into host cells, while mutations in the E2 protein reduce antibody neutralization. Changes in nsP3 are connected to more replication and disease problems. It is difficult to diagnose, treat, and make vaccines for them. The continuous genetic monitoring of viruses is important to check the new variants that are emerging. A comprehensive approach including better diagnostics, selective vector control, vaccine development, and community-based management would help mitigate CHIKV impact. Through illuminating the link between viral evolution and clinical outcomes, the current review aims to stimulate future research and reinforce preparedness against this ever-evolving virus.
- 29 May 2025
- Published by Elsevier in Journal of Clinical Virology
- Vol. 179, 105809
The evolving landscape of Norovirus GII genotypes in Asia: A systematic review and meta-analysis
- 29 May 2025
- Published by Elsevier in Journal of Clinical Virology
- Vol. 179, 105809
The evolving landscape of Norovirus GII genotypes in Asia: A systematic review and meta-analysis
- Open Access
- 31 December 2024
- Published by Scientific Scholar in Journal of Reproductive Healthcare and Medicine
- Vol. 5, 17
Genital tuberculosis: A silent contributor to infertility and adverse pregnancy outcomes
Genital tuberculosis (GTB) is a significant yet often unnoticed reason for infertility, disproportionately affecting women in areas with a high burden of tuberculosis (TB). Notwithstanding its considerable effect on reproductive health, GTB remains underdiagnosed due to its inconspicuous clinical presentation and the limits of existing diagnostic tools. This review gives a top-to-bottom examination of the epidemiological patterns and physiological impacts of GTB, featuring the intricate interchange between illness and infertility. The discussion envelops the complex difficulties in diagnosing GTB-associated infertility, which incorporate the nonspecific symptoms, the absence of delicate and explicit diagnostic tests, and the potential for misdiagnosis with other gynecological conditions. Furthermore, we investigate the ongoing pharmacological medications used to treat GTB, focusing on their efficacy, limitations, and the emergence of drug-resistant TB strains that complicate treatment outcomes.
- 31 December 2024
- Published by Scientific Scholar in Journal of Reproductive Healthcare and Medicine
- Vol. 5, 17
Open AccessGenital tuberculosis: A silent contributor to infertility and adverse pregnancy outcomes
Genital tuberculosis (GTB) is a significant yet often unnoticed reason for infertility, disproportionately affecting women in areas with a high burden of tuberculosis (TB). Notwithstanding its considerable effect on reproductive health, GTB remains underdiagnosed due to its inconspicuous clinical presentation and the limits of existing diagnostic tools. This review gives a top-to-bottom examination of the epidemiological patterns and physiological impacts of GTB, featuring the intricate interchange between illness and infertility. The discussion envelops the complex difficulties in diagnosing GTB-associated infertility, which incorporate the nonspecific symptoms, the absence of delicate and explicit diagnostic tests, and the potential for misdiagnosis with other gynecological conditions. Furthermore, we investigate the ongoing pharmacological medications used to treat GTB, focusing on their efficacy, limitations, and the emergence of drug-resistant TB strains that complicate treatment outcomes.
- Open Access
- 11 October 2024
- Published by Elsevier in Science in One Health
- Vol. 3, 100080
Protocol for detection of pathogenic enteric RNA viruses by regular monitoring of environmental samples from wastewater treatment plants using droplet digital PCR
- 11 October 2024
- Published by Elsevier in Science in One Health
- Vol. 3, 100080
Open AccessProtocol for detection of pathogenic enteric RNA viruses by regular monitoring of environmental samples from wastewater treatment plants using droplet digital PCR
- Open Access
Detection of Noroviruses GII in wastewater samples of Bhopal, India, using Droplet Digital PCR
Noroviruses are a significant cause of global gastroenteritis outbreaks, underscoring the importance of effective surveillance. Wastewater-based epidemiology helps identify viral pathogens in communities. Recent advancements in wastewater-based molecular surveillance have shown that viruses can be detected in feces and urine early, making sewage monitoring an essential tool for tracking viral presence. We aimed to create and validate a new method for detecting and monitoring Noroviruses GII in Bhopal’s wastewater using Automated Droplet Digital PCR (ddPCR) technology. In this study, a ddPCR assay targeting the ORF1-2 region of Norovirus GII was developed, allowing viral nucleic acid quantification without a standard curve. A total of 27 samples from five Sewage Treatment Plants located in Bhopal city were collected during the summer season (April and May 2023) at fortnightly intervals and analyzed for the presence of Norovirus using the novel ddPCR assay. Among the samples tested, 33% tested positive for Norovirus, with the highest detection rate observed as 72.72%, followed by 25%. The concentrations of Noroviruses GII in positive samples ranged from 0.06 to 6.60 copies/µl. These findings indicate a potentially higher patient population within Bansal Hospital’s catchment area than the other STPs in the Bhopal region. The study underscores Norovirus’s varying prevalence and distribution in wastewater across different STPs in Bhopal. Moreover, it demonstrates the utility of wastewater surveillance and digital PCR in accurately and specifically detecting Norovirus in wastewater. The practical application of this wastewater surveillance strategy could serve as an early warning system for communities, enabling timely preparedness for impending viral outbreaks, implementation of effective administrative containment measures, and intensified vaccination campaigns.
Open AccessDetection of Noroviruses GII in wastewater samples of Bhopal, India, using Droplet Digital PCR
Noroviruses are a significant cause of global gastroenteritis outbreaks, underscoring the importance of effective surveillance. Wastewater-based epidemiology helps identify viral pathogens in communities. Recent advancements in wastewater-based molecular surveillance have shown that viruses can be detected in feces and urine early, making sewage monitoring an essential tool for tracking viral presence. We aimed to create and validate a new method for detecting and monitoring Noroviruses GII in Bhopal’s wastewater using Automated Droplet Digital PCR (ddPCR) technology. In this study, a ddPCR assay targeting the ORF1-2 region of Norovirus GII was developed, allowing viral nucleic acid quantification without a standard curve. A total of 27 samples from five Sewage Treatment Plants located in Bhopal city were collected during the summer season (April and May 2023) at fortnightly intervals and analyzed for the presence of Norovirus using the novel ddPCR assay. Among the samples tested, 33% tested positive for Norovirus, with the highest detection rate observed as 72.72%, followed by 25%. The concentrations of Noroviruses GII in positive samples ranged from 0.06 to 6.60 copies/µl. These findings indicate a potentially higher patient population within Bansal Hospital’s catchment area than the other STPs in the Bhopal region. The study underscores Norovirus’s varying prevalence and distribution in wastewater across different STPs in Bhopal. Moreover, it demonstrates the utility of wastewater surveillance and digital PCR in accurately and specifically detecting Norovirus in wastewater. The practical application of this wastewater surveillance strategy could serve as an early warning system for communities, enabling timely preparedness for impending viral outbreaks, implementation of effective administrative containment measures, and intensified vaccination campaigns.
- 17 February 2010
- Published by Springer Nature in Journal of Biosciences
- Vol. 35 (1) , 79-86
Evidence of a humoral immune response against the prokaryotic expressed N-terminal autoprotease (Npro) protein of bovine viral diarrhoea virus
Bovine viral diarrhoea virus (BVDV) is an economically important pathogen of cattle and sheep belonging to the genus Pestivirus of the family Flaviviridae. Although the BVDV non-structural N-terminal protease (Npro) acts as an interferon antagonist and subverts the host innate immunity, little is known about its immunogenicity. Hence, we expressed a recombinant BVDV Npro-His fusion protein (28 kDa) in E. coli and determined the humoral immune response generated by it in rabbits. The antigenicity of the Npro protein was confirmed by western blot using anti-BVDV hyperimmune cattle, sheep and goat serum, and anti-Npro rabbit serum. When rabbits were immunized with the Npro protein, a humoral immune response was evident by 4 weeks and persisted till 10 weeks post immunization as detected by ELISA and western blot. Despite Npro-specific antibodies remaining undetectable in 80 serum samples from BVDV-infected sheep and goats, BVDV hyperimmune sera along with some of the field cattle, sheep and goat sera with high BVDV neutralizing antibody titres were found positive for Npro antibodies. Our results provide evidence that despite the low immunogenicity of the BVDV Npro protein, a humoral immune response is induced in cattle, sheep and goats only with repeated BVDV exposure.
- 17 February 2010
- Published by Springer Nature in Journal of Biosciences
- Vol. 35 (1) , 79-86
Evidence of a humoral immune response against the prokaryotic expressed N-terminal autoprotease (Npro) protein of bovine viral diarrhoea virus
Bovine viral diarrhoea virus (BVDV) is an economically important pathogen of cattle and sheep belonging to the genus Pestivirus of the family Flaviviridae. Although the BVDV non-structural N-terminal protease (Npro) acts as an interferon antagonist and subverts the host innate immunity, little is known about its immunogenicity. Hence, we expressed a recombinant BVDV Npro-His fusion protein (28 kDa) in E. coli and determined the humoral immune response generated by it in rabbits. The antigenicity of the Npro protein was confirmed by western blot using anti-BVDV hyperimmune cattle, sheep and goat serum, and anti-Npro rabbit serum. When rabbits were immunized with the Npro protein, a humoral immune response was evident by 4 weeks and persisted till 10 weeks post immunization as detected by ELISA and western blot. Despite Npro-specific antibodies remaining undetectable in 80 serum samples from BVDV-infected sheep and goats, BVDV hyperimmune sera along with some of the field cattle, sheep and goat sera with high BVDV neutralizing antibody titres were found positive for Npro antibodies. Our results provide evidence that despite the low immunogenicity of the BVDV Npro protein, a humoral immune response is induced in cattle, sheep and goats only with repeated BVDV exposure.
- Open Access
- 1 January 2004
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 17 (10) , 1374-1377
Estrus Behavior and Superovulatory Response in Black Bengal Goats (Capra hircus) Following Administration of Prostaglandin and Gonadotropins
- 1 January 2004
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 17 (10) , 1374-1377
Open AccessEstrus Behavior and Superovulatory Response in Black Bengal Goats (Capra hircus) Following Administration of Prostaglandin and Gonadotropins